Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2011-01-01–present
Board Member
Biocryst Pharmaceuticals Inc (BCRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Biocryst Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get BCRX alertsGeorge B. Abercrombie is recorded as Board Member at Biocryst Pharmaceuticals Inc (BCRX) since June 13, 2023. Biocryst Pharmaceuticals Inc reported in an 8-K filed June 16, 2025 that George B. Abercrombie retired as Board of Directors. The same filing states: “Mr. Abercrombie cited no disagreement with the Board or management relating to the Company, its operations, policies, or practices.” Biocryst Pharmaceuticals Inc reported in an 8-K filed June 14, 2023 that George B. Abercrombie was appointed director, effective June 13, 2023. Biocryst Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Biocryst Pharmaceuticals Inc includes Charles Gayer (CEO and Board Member), Charlie Gayer (CEO and Board Member), Vincent J. Milano (Chairman and Board Member) and 7 others.
“On June 11, 2025, George B. Abercrombie notified BioCryst Pharmaceuticals, Inc., a Delaware corporation (the "Company"), of his intention to retire from the Board of Directors of the Company (the "Board"), effective as of the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting").”
“Mr. Abercrombie cited no disagreement with the Board or management relating to the Company, its operations, policies, or practices.”
“The nominees for director were elected by the following votes:”
2023-06-13–present
2011-01-01–2025-06-16
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2011-01-01–present
“Mr. Abercrombie cited no disagreement with the Board or management relating to the Company, its operations, policies, or practices.”
Biocryst Pharmaceuticals Inc (BCRX)